Back to KROS
PRICE T ROWE ASSOCIATES INC /MD/ → KROS
PRICE T ROWE ASSOCIATES INC /MD/ KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$662K
Q3 2026
Peak value
$662K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $605K |
| Q1 2026 | $507K |
| Q2 2026 | $601K |
| Q3 2026 | $662K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $662K | 58.0K | — | — |
| Q2 2026 | $601K | 56.1K | — | — |
| Q1 2026 | $507K | 45.9K | — | — |
| Q4 2025 | $605K | 29.7K | — | — |